Mlakar J, Preložnik Zupan I, Kralj E, Trontelj J, Lusa L, Grat M, Fikfak N, Umek Bricman I, Čeh M, Petric V, Pajič T. Imatinib plasma concentration – a new laboratory parameter for monitoring the treatment of Slovenian patients with chronic myeloid leukemia. TEST ZdravVestn [Internet]. 1Mar.2011 [cited 11Sep.2024];80(3). Available from: http://vestnik-dev.szd.si/index.php/ZdravVest/article/view/425